Delirium Clinical Trial
Official title:
Effectiveness and Safety of a Flexible Family Visitation Model for Delirium Prevention in Adult Intensive Care Units: a Cluster-randomized, Crossover Trial
NCT number | NCT02932358 |
Other study ID # | ICU Visits |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | April 28, 2017 |
Est. completion date | June 22, 2018 |
Verified date | November 2018 |
Source | Hospital Moinhos de Vento |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A cluster-randomized crossover trial involving adult ICU patients, family members, and ICU professionals will be conducted. Forty medical-surgical Brazilian ICUs with visiting hours <4.5 h/day will be randomly assigned to either a restrictive family visitation model (RFVM) (visits according to local policies) or a flexible family visitation model (FFVM) (visitation during 12 consecutive hours per day) at a 1:1 ratio. After enrollment and follow-up of 25 patients, each ICU will be switched over to the other visitation model, until 25 more patients per site are enrolled and followed. The primary outcome will be the cumulative incidence of delirium among ICU patients, measured twice a day using the Confusion Assessment Method for the ICU. Secondary outcome measures will include daily hazard of delirium, ventilator-free days at day 7, any ICU-acquired infections, ICU length of stay, and all-cause hospital mortality among the patients; symptoms of anxiety and depression and satisfaction among the family members; and prevalence of symptoms of burnout among the ICU professionals. Tertiary outcomes will include need for antipsychotic agents and/or mechanical restraints, coma-free days at day 7, unplanned loss of invasive devices, and ICU-acquired pneumonia, urinary tract infection, or bloodstream infection among the patients; self-perception of involvement in patient care among the family members; and satisfaction among the ICU professionals.
Status | Completed |
Enrollment | 1650 |
Est. completion date | June 22, 2018 |
Est. primary completion date | June 22, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - For ICUs: medical-surgical ICUs of of public and philanthropic Brazilian hospitals with restricted visitation policies(<4.5 hours/day). - For Patients: Age = 18 years, admission to the intensive care unit. - For Patient's Family Members: nearest relative of the ICU patient recruited in the study and consent to participate in the study. - For ICU Workers: ICU workers that assist patients in the ICU during the daytime for at least 20 hours per week and consent to participate in the study. Exclusion Criteria: - For ICUs: ICUs with structural or organizational impediments to extended visitation. - For Patients: Subjects with coma (Richmond Agitation Sedation Scale -4 or -5) lasting > 96 hours from the moment of first evaluation for recruitment, or delirium at the baseline (positive Confusion Assessment Method for ICU) will be excluded. Individuals with cerebral death, aphasia, severe hearing deficit, a prediction of ICU length of stay < 48 hours, exclusively palliative treatment, or without a familiar member able to participate in extended ICU visits and those who are prisioners, unlikely to survive >24hs, re-admitted to the ICU after enrolment in the study will also be excluded. - For Patient's Family Members: Another ICU patient's relative enrolled in the study; family members who don't speak Portuguese; Difficulty to answer the self-administered questionnaires (e.g.: illiteracy) - For ICU Workers: ICU workers who have a prediction of withdrawal of ICU care activities >15 days during the study will be excluded. |
Country | Name | City | State |
---|---|---|---|
Brazil | Hospital das Clínicas da Universidade Federal de Minas Gerais | Belo Horizonte | MG |
Brazil | Hospital Tacchini | Bento Gonçalves | RS |
Brazil | Hospital Universitário Alcides Carneiro | Campina Grande | PB |
Brazil | Hospital do Caâncer de Cascavel (UOPECCAN) | Cascavel | PR |
Brazil | Hospital Universitário do Oeste do Paraná (UNIOESTE) | Cascavel | PR |
Brazil | Hospital São Camilo de Esteio | Esteio | RS |
Brazil | Hospital Geral Clériston Andrade | Feira De Santana | BA |
Brazil | Hospital INCARDIO | Feira De Santana | BA |
Brazil | Hospital de Urgências de Goiânia | Goiânia | Goias |
Brazil | Hospital Alberto Urquiza Wanderley (UNIMED João Pessoa) | João | |
Brazil | Hospital Universitário Lauro Wanderley | João Pessoa | PB |
Brazil | Hospital Dona Helena | Joinville | SC |
Brazil | Fundação Hospital Adriano Jorge | Manaus | AM |
Brazil | Hospital Montenegro | Montenegro | |
Brazil | Hospital Geral de Nova Iguaçú | Nova Iguaçú | RJ |
Brazil | Hospital Deoclécio Marques de Lucena | Parnamirim | RN |
Brazil | Hospital da Cidade de Passo Fundo | Passo Fundo | RS |
Brazil | Hospital Universitário de Petrolina | Petrolina | PE |
Brazil | Hospital de Clínicas de Porto Alegre | Porto Alegre | RS |
Brazil | Hospital Dom Vicente Scherer | Porto Alegre | RS |
Brazil | Hospital Mãe de Deus | Porto Alegre | RS |
Brazil | Hospital Nossa Senhora da Conceiçaão | Porto Alegre | RS |
Brazil | Hospital Santa Rita | Porto Alegre | RS |
Brazil | Pavilhão Pereira Filho | Porto Alegre | RS |
Brazil | Hospital Agamenom Magalhães | Recife | PE |
Brazil | Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto | Ribeirão Preto | SP |
Brazil | Hospital de Urgência e Emergência de Rio Branco | Rio Branco | AC |
Brazil | Hospital Ana Nery | Santa Cruz Do Sul | RS |
Brazil | Hospital Santa Cruz | Santa Cruz Do Sul | RS |
Brazil | Hospital Regional do Baixo Amazonas | Santarém | PA |
Brazil | Santa Casa de Misericórdia de São João Del Rei | São João Del Rei | MG |
Brazil | Hospital do Coração (HCor) | São Paulo | SP |
Brazil | Hospital Universitário da Universidade Federal do Piauí | Teresina | PI |
Lead Sponsor | Collaborator |
---|---|
Hospital Moinhos de Vento | Ministry of Health, Brazil |
Brazil,
Rosa RG, Falavigna M, Robinson CC, da Silva DB, Kochhann R, de Moura RM, Santos MMS, Sganzerla D, Giordani NE, Eugênio C, Ribeiro T, Cavalcanti AB, Bozza F, Azevedo LCP, Machado FR, Salluh JIF, Pellegrini JAS, Moraes RB, Hochegger T, Amaral A, Teles JMM, da Luz LG, Barbosa MG, Birriel DC, Ferraz IL, Nobre V, Valentim HM, Corrêa E Castro L, Duarte PAD, Tregnago R, Barilli SLS, Brandão N, Giannini A, Teixeira C; ICU Visits Study Group Investigators and the BRICNet. Study protocol to assess the effectiveness and safety of a flexible family visitation model for delirium prevention in adult intensive care units: a cluster-randomised, crossover trial (The ICU Visits Study). BMJ Open. 2018 Apr 13;8(4):e021193. doi: 10.1136/bmjopen-2017-021193. — View Citation
Sganzerla D, Teixeira C, Robinson CC, Kochhann R, Santos MMS, de Moura RM, Barbosa MG, da Silva DB, Ribeiro T, Eugênio C, Schneider D, Mariani D, Jeffman RW, Bozza F, Cavalcanti AB, Azevedo LCP, Machado FR, Salluh JI, Pellegrini JAS, Moraes RB, Damiani LP, da Silva NB, Falavigna M, Rosa RG. Statistical analysis plan for a cluster-randomized crossover trial comparing the effectiveness and safety of a flexible family visitation model for delirium prevention in adult intensive care units (the ICU Visits Study). Trials. 2018 Nov 19;19(1):636. doi: 10.1186/s13063-018-3006-8. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of Delirium among ICU patients | Incidence of delirium will be verified by trained intensive care professionals with the confusion assessment method for the ICU 2 times per day. | During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up) | |
Secondary | Daily hazard of delirium among ICU patients | The daily hazard of delirium will be analyzed using a joint survival model that accounts for the treatment effect on repeated daily indicator of delirium (Confusion Assessment Method for the ICU) within each patient and terminating event (death or discharge from the ICU). | During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up) | |
Secondary | Antipsychotic use among ICU patients | Need of antipsychotic use during ICU stay | During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up) | |
Secondary | Need of mechanical restraints among ICU patients | Need of mechanical restraints among ICU patients during ICU stay | During ICU stay (from randomization until ICU discharge, or death, or a maximum of 30 days of follow-up) | |
Secondary | Coma-free days at day 7 among ICU patients | Days alive and free of coma (Richmond Agitation Sedation Scale -4 or -5) during ICU stay. | During the first 7 days following patient enrollment. | |
Secondary | Unplanned loss of invasive devices among ICU patients | Unplanned loss of venous catheter, tube feeding or urinary catheter | During ICU stay (from randomization until ICU discharge, or death, or a maximum of 30 days of follow-up) | |
Secondary | Mechanical ventilation-free days at day 7 among ICU patients | Days alive and free of mechanical ventilation during ICU stay. | During the first 7 days following patient enrollment. | |
Secondary | Any ICU-acquired infection among ICU patients | Pneumonia or bloodstream infection or urinary tract infection acquired after 48 hours of ICU admission. | During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up) | |
Secondary | ICU-acquired pneumonia among ICU patients | Pneumonia acquired after 48 hours of ICU admission. | During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up) | |
Secondary | ICU-acquired bloodstream infection among ICU patients | Bloodstream infection acquired after 48 hours of ICU admission. | During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up) | |
Secondary | ICU-acquired urinary tract infection among ICU patients | Urinary tract infection acquired after 48 hours of ICU admission. | During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up) | |
Secondary | ICU length of stay among ICU patients | Length of ICU stay in days | During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up) | |
Secondary | All-cause hospital mortality among ICU patients | rates of all-cause mortality during hospital stay | During hospital stay (from enrollment until hospital discharge, or death or a maximum of 30 days of follow-up) | |
Secondary | Symptoms of anxiety among family members | symptoms of anxiety among family members measured by the Hospital Anxiety and Depression scale | IOn the day of patient discharge from ICU, or death or a maximum of 30 days of follow-up. | |
Secondary | Symptoms of depression among family members | symptoms of depression among family members measured by the Hospital Anxiety and Depression scale | On the day of patient discharge from ICU, or death or a maximum of 30 days of follow-up. | |
Secondary | Satisfaction among among family members | Rates of patient's families satisfaction measured by the critical care family needs inventory | On the day of patient discharge from ICU, or death or a maximum of 30 days of follow-up. | |
Secondary | Prevalence of Burnout Syndrome among ICU professionals | Prevalence of Burnout Syndrome among ICU workers measured by the Maslach Burnout Inventory | It will be measured in two moments: within 15 days prior to the first ICU intervention and between the 15th and 30th days of the period in which no patient will be enrolled. | |
Secondary | Satisfaction with the current ICU visiting policy among ICU professionals | Satisfaction with the current ICU visiting policy among ICU professionals | It will be measured between the 15th and 30th days of the period in which no patient will be enrolled. | |
Secondary | Any adverse event related to ICU visitation | Any adverse event possible related to the ICU visitation model | During ICU stay (from randomization until ICU discharge, or death, or a maximum of 30 days of follow-up) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04551508 -
Delirium Screening 3 Methods Study
|
||
Recruiting |
NCT05891873 -
Delirium in the (Neuro)Intensive/Critical Care in the Adult and Paediatric Czech Populations
|
||
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT04792983 -
Cognition and the Immunology of Postoperative Outcomes
|
||
Recruiting |
NCT06194474 -
Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients
|
||
Completed |
NCT03095417 -
Improving the Recovery and Outcome Every Day After the ICU
|
N/A | |
Completed |
NCT05395559 -
Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
|
||
Terminated |
NCT03337282 -
Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
|
||
Not yet recruiting |
NCT04846023 -
Pediatric Delirium Screening in the PICU Via EEG
|
N/A | |
Not yet recruiting |
NCT04538469 -
Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
|
||
Not yet recruiting |
NCT03807388 -
ReMindCare App for Patients From First Episode of Psychosis Unit.
|
N/A | |
Withdrawn |
NCT02673450 -
PER3 Clock Gene Polymorphism, Clock Gene Expression and Delirium in the Intensive Care Unit.
|
||
Recruiting |
NCT03256500 -
Transcranial Direct Current Stimulation for the Treatment of Delirium
|
N/A | |
Not yet recruiting |
NCT02892968 -
ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients
|
N/A | |
Completed |
NCT02890927 -
Geriatric-CO-mAnagement for Cardiology Patients in the Hospital
|
N/A | |
Recruiting |
NCT03165539 -
Cerebral Oxygen Desaturation and Post-Operative Delirium in Thoracic Surgical Patients
|
||
Completed |
NCT02518646 -
DElirium prediCtIon in the intenSIve Care Unit: Head to Head comparisON of Two Delirium Prediction Models
|
N/A | |
Completed |
NCT02554253 -
The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction
|
Phase 2 | |
Recruiting |
NCT02305589 -
The Clinical Changes Before and After Sugammadex in the Patients Undergoing Hip Surgery on the Aspect of Delirium
|
N/A | |
Completed |
NCT02628925 -
Nu-DESC DK: The Danish Version of the Nursing Delirium Screening Scale
|
N/A |